viatris inc. - VTRS

VTRS

Close Chg Chg %
13.37 -0.13 -0.93%

Open Market

13.25

-0.13 (0.93%)

Volume: 1.32M

Last Updated:

Mar 27, 2026, 12:55 PM EDT

Company Overview: viatris inc. - VTRS

VTRS Key Data

Open

$13.35

Day Range

13.23 - 13.39

52 Week Range

6.85 - 16.47

Market Cap

$15.39B

Shares Outstanding

1.15B

Public Float

1.13B

Beta

0.77

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.96

Yield

359.01%

Dividend

$0.12

EX-DIVIDEND DATE

Mar 9, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

11.72M

 

VTRS Performance

1 Week
 
1.29%
 
1 Month
 
-10.45%
 
3 Months
 
8.52%
 
1 Year
 
54.03%
 
5 Years
 
-6.89%
 

VTRS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About viatris inc. - VTRS

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

VTRS At a Glance

Viatris, Inc.
Robert J. Coury Global Center
Canonsburg, Pennsylvania 15317
Phone 1-724-514-1800 Revenue 14.29B
Industry Pharmaceuticals: Major Net Income -3,514,900,000.00
Sector Health Technology Employees 30,000
Fiscal Year-end 12 / 2026
View SEC Filings

VTRS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.02
Price to Book Ratio 0.974
Price to Cash Flow Ratio 6.29
Enterprise Value to EBITDA 7.158
Enterprise Value to Sales 1.947
Total Debt to Enterprise Value 0.528

VTRS Efficiency

Revenue/Employee 476,440.00
Income Per Employee -117,163.333
Receivables Turnover 4.27
Total Asset Turnover 0.363

VTRS Liquidity

Current Ratio 1.30
Quick Ratio 0.736
Cash Ratio 0.205

VTRS Profitability

Gross Margin 39.519
Operating Margin 8.133
Pretax Margin -25.642
Net Margin -24.591
Return on Assets -8.933
Return on Equity -21.081
Return on Total Capital -11.95
Return on Invested Capital -11.673

VTRS Capital Structure

Total Debt to Total Equity 99.933
Total Debt to Total Capital 49.983
Total Debt to Total Assets 39.527
Long-Term Debt to Equity 86.047
Long-Term Debt to Total Capital 43.038
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Viatris Inc. - VTRS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
16.17B 15.38B 14.71B 14.29B
Sales Growth
-9.42% -4.90% -4.37% -2.83%
Cost of Goods Sold (COGS) incl D&A
9.49B 8.81B 8.49B 8.64B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.85B 2.68B 2.71B 2.72B
Depreciation
349.50M 362.10M 357.00M 374.60M
Amortization of Intangibles
2.50B 2.32B 2.35B 2.35B
COGS Growth
-18.65% -7.08% -3.73% +1.88%
Gross Income
6.69B 6.57B 6.22B 5.65B
Gross Income Growth
+7.94% -1.80% -5.23% -9.25%
Gross Profit Margin
+41.35% +42.70% +42.32% +39.52%
2022 2023 2024 2025 5-year trend
SG&A Expense
4.18B 4.51B 4.36B 4.49B
Research & Development
660.80M 793.00M 802.90M 952.50M
Other SG&A
3.52B 3.72B 3.56B 3.53B
SGA Growth
-7.72% +8.03% -3.34% +2.80%
Other Operating Expense
- - - -
-
Unusual Expense
1.07B 1.28B 1.59B 4.45B
EBIT after Unusual Expense
1.44B 777.20M 269.10M (3.28B)
Non Operating Income/Expense
1.96B 600.00K (337.60M) 97.90M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
587.90M 574.90M 554.70M 478.20M
Interest Expense Growth
-6.96% -2.21% -3.51% -13.79%
Gross Interest Expense
587.90M 574.90M 554.70M 478.20M
Interest Capitalized
- - - -
-
Pretax Income
2.81B 202.90M (623.20M) (3.67B)
Pretax Income Growth
+523.42% -92.79% -407.15% -488.09%
Pretax Margin
+17.39% +1.32% -4.24% -25.64%
Income Tax
734.60M 148.20M 11.00M (150.10M)
Income Tax - Current - Domestic
141.80M 4.50M 120.20M (115.10M)
Income Tax - Current - Foreign
618.70M 530.80M 658.40M 441.50M
Income Tax - Deferred - Domestic
284.00M 296.00M (120.40M) (300.90M)
Income Tax - Deferred - Foreign
(309.90M) (683.10M) (647.20M) (175.60M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.08B 54.70M (634.20M) (3.51B)
Minority Interest Expense
- - - -
-
Net Income
2.08B 54.70M (634.20M) (3.51B)
Net Income Growth
+263.79% -97.37% -1,259.41% -454.23%
Net Margin Growth
+12.85% +0.36% -4.31% -24.59%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.08B 54.70M (634.20M) (3.51B)
Preferred Dividends
- - - -
-
Net Income Available to Common
2.08B 54.70M (634.20M) (3.51B)
EPS (Basic)
1.7149 0.0456 -0.5315 -3.0024
EPS (Basic) Growth
+263.34% -97.34% -1,265.57% -464.89%
Basic Shares Outstanding
1.21B 1.20B 1.19B 1.17B
EPS (Diluted)
1.7074 0.0453 -0.5315 -3.0024
EPS (Diluted) Growth
+262.63% -97.35% -1,273.29% -464.89%
Diluted Shares Outstanding
1.22B 1.21B 1.19B 1.17B
EBITDA
5.36B 4.73B 4.57B 3.89B
EBITDA Growth
+9.92% -11.76% -3.44% -14.93%
EBITDA Margin
+33.16% +30.77% +31.06% +27.19%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 15.625
Number of Ratings 12 Current Quarters Estimate 0.502
FY Report Date 03 / 2026 Current Year's Estimate 2.445
Last Quarter’s Earnings 0.57 Median PE on CY Estimate N/A
Year Ago Earnings 2.35 Next Fiscal Year Estimate 2.655
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 9 8
Mean Estimate 0.50 0.60 2.44 2.66
High Estimates 0.59 0.63 2.50 3.04
Low Estimate 0.45 0.57 2.41 2.29
Coefficient of Variance 8.26 3.38 1.44 7.88

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 2
OVERWEIGHT 1 1 2
HOLD 5 6 7
UNDERWEIGHT 2 1 2
SELL 0 0 0
MEAN Overweight Overweight Hold

Viatris Inc. in the News